MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disorder marked by neurotoxic protein aggregates, composed mainly by amyloid-beta (Aβ) peptides and hyper-phosphorylated tau protein (p-tau) accumulating within the brain.